The University of California, Davis and InVixa Inc., a biopharmaceutical startup, have executed a licensing agreement for a novel method using inhaled statins to treat the severe respiratory disease known... Read More
Author Archives:
Update on COVID-19 Research Operations on Campus
1/12/2021 Campus leadership recently announced plans for a return to primarily in-person instruction starting fall 2021 while remaining vigilant in all critical prevention efforts and continuing to prioritize the health and... Read More
Campus Curtailment Impact on Research Support Operations
Updated December 7, 2020 UC Davis has announced a Davis campus curtailment program for six workdays between December 21, 2020, and January 4, 2021. Although the campus has modified the... Read More
Jennifer Doudna on CRISPR, coronavirus and curiosity-driven research
Last week, Jennifer Doudna, the 2020 Nobel Laureate in Chemistry, gave a fascinating talk to an online audience of more than 1,600 viewers. She shared her journey in co-developing the... Read More
Call to Enter Phase 2x of the On-Campus Research Ramp-Up Plan
Considering the current infection trends in Yolo and Sacramento counties, we will not be moving on to Phase 3 until our saliva testing facility scales up. However, we will have... Read More
Launch Event: Research Pathways to Impact
Please join us for a conversation on how new approaches in team science are leading to unprecedented advances in research outcomes across disciplines. Panelists will include Vice Chancellor for Research Prasant... Read More
Distinguished Speaker Series in Research and Innovation – 2020 Nobel Laureate Jennifer Doudna
Guest Speaker Jennifer Doudna, Ph.D. Howard Hughes Medical Institute investigator at UC Berkeley Founder of the Innovative Genomics Institute Recipient of the 2020 Nobel Prize in Chemistry for the development... Read More